ResearcherJuntendo UniversityActive in the last 2 years
Akio Saiura
Matched on ORCID iD 0000-0001-9494-5993; OpenAlex author ID A5084836163, A5110120595. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 40
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Pancreatic Cancer after Living-Donor Liver Transplantation: A Case Report of Long-Term Recurrence-Free Survival after Pancreaticoduodenectomy Followed by Adjuv… Co-author DOI 10.70352/scrj.cr.26-0464↗
- Early-onset pancreatic cancer: Clinical characteristics and survival outcomes. Co-author DOI 10.1016/j.pan.2022.04.003↗
- Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study. Co-author DOI 10.1097/mpa.0000000000001702↗
- Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Co-author DOI 10.1007/s00423-019-01846-2↗
- Techniques for splenic vein reconstruction after pancreaticoduodenectomy with portal vein resection for pancreatic cancer. Last author DOI 10.1016/j.hpb.2019.01.017↗
- Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes? First author DOI 10.1007/s11605-017-3421-2↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akio Saiura · 2 shared papers, 2020–2026 · strength 0.41
- Yosuke Inoue · 4 shared papers, 2017–2022 · strength 0.40
- Paper Early-onset pancreatic cancer: Clinical characteristics and survival outcomes. DOI 10.1016/j.pan.2022.04.003↗
- Paper Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? DOI 10.1007/s00423-019-01846-2↗
- Paper Techniques for splenic vein reconstruction after pancreaticoduodenectomy with portal vein resection for pancreatic canc… DOI 10.1016/j.hpb.2019.01.017↗
- Yu Takahashi · 4 shared papers, 2017–2022 · strength 0.40
- Paper Early-onset pancreatic cancer: Clinical characteristics and survival outcomes. DOI 10.1016/j.pan.2022.04.003↗
- Paper Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? DOI 10.1007/s00423-019-01846-2↗
- Paper Techniques for splenic vein reconstruction after pancreaticoduodenectomy with portal vein resection for pancreatic canc… DOI 10.1016/j.hpb.2019.01.017↗
- Yoshinori Takeda · 2 shared papers, 2017–2026 · strength 0.37
- Naoki Matsuya · 1 shared paper, 2026 · strength 0.30
- Ryuji Yoshioka · 1 shared paper, 2026 · strength 0.30
- Hiromichi Ito · 3 shared papers, 2017–2020 · strength 0.27
- Paper Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? DOI 10.1007/s00423-019-01846-2↗
- Paper Techniques for splenic vein reconstruction after pancreaticoduodenectomy with portal vein resection for pancreatic canc… DOI 10.1016/j.hpb.2019.01.017↗
- Paper Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes? DOI 10.1007/s11605-017-3421-2↗
- Naoki Sasahira · 2 shared papers, 2021–2022 · strength 0.23
- Yoshihiro Ono · 2 shared papers, 2019–2020 · strength 0.21
- Masayuki Tanaka · 2 shared papers, 2017–2019 · strength 0.16
- Takashi Sasaki · 1 shared paper, 2022 · strength 0.13
- Takeshi Okamoto · 1 shared paper, 2022 · strength 0.13
- Tsuyoshi Takeda · 1 shared paper, 2022 · strength 0.13
- Akiyoshi Kasuga · 1 shared paper, 2022 · strength 0.13
- Masato Ozaka · 1 shared paper, 2022 · strength 0.13
- Takafumi Mie · 1 shared paper, 2022 · strength 0.13
- Yuto Yamada · 1 shared paper, 2022 · strength 0.13
- Takaaki Furukawa · 1 shared paper, 2022 · strength 0.13
- Masato Matsuyama · 1 shared paper, 2022 · strength 0.13
- Atsushi Oba · 1 shared paper, 2020 · strength 0.11
- Akira Fukutomi · 1 shared paper, 2021 · strength 0.10
- Shoji Nakamori · 1 shared paper, 2021 · strength 0.10
- Tatsuyuki Takadate · 1 shared paper, 2021 · strength 0.10
- Kumiko Umemoto · 1 shared paper, 2021 · strength 0.10
- Yasuji Seyama · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.